These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9862279)

  • 1. Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover.
    Yu PH; Deng YL
    Atherosclerosis; 1998 Oct; 140(2):357-63. PubMed ID: 9862279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet.
    Yu PH; Wang M; Deng YL; Fan H; Shira-Bock L
    Diabetologia; 2002 Sep; 45(9):1255-62. PubMed ID: 12242458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury.
    Yu PH; Zuo DM
    Atherosclerosis; 1996 Feb; 120(1-2):189-97. PubMed ID: 8645360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine.
    Gubisne-Haberle D; Hill W; Kazachkov M; Richardson JS; Yu PH
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1125-32. PubMed ID: 15128865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity.
    Yu PH
    Neurochem Res; 1998 Sep; 23(9):1205-10. PubMed ID: 9712192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endogenous formaldehyde and cardiovascular diseases].
    Zhang FW; Du JB; Tang CS
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):17-21. PubMed ID: 21417009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic imaging of formaldehyde adducts in mice: possible relevance for vascular damage in diabetes.
    Grönvall JL; Garpenstrand H; Oreland L; Ekblom J
    Life Sci; 1998; 63(9):759-68. PubMed ID: 9740313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications.
    Deng Y; Yu PH
    J Chromatogr Sci; 1999 Sep; 37(9):317-22. PubMed ID: 10497785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase.
    Boor PJ; Trent MB; Lyles GA; Tao M; Ansari GA
    Toxicology; 1992; 73(3):251-8. PubMed ID: 1631902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deamination of methylamine and aminoacetone increases aldehydes and oxidative stress in rats.
    Deng Y; Boomsma F; Yu PH
    Life Sci; 1998; 63(23):2049-58. PubMed ID: 9839528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
    Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
    Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of semicarbazide-sensitive amine oxidase inhibitors on morphology of aorta and kidney in diabetic rats.
    Li C; Wang Z; Li X; Chen J
    BMC Endocr Disord; 2019 Jun; 19(1):59. PubMed ID: 31182088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for in vivo scavenging by aminoguanidine of formaldehyde produced via semicarbazide-sensitive amine oxidase-mediated deamination.
    Kazachkov M; Chen K; Babiy S; Yu PH
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1201-7. PubMed ID: 17596537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultured rat vascular smooth muscle cells are resistant to methylamine toxicity: no correlation to semicarbazide-sensitive amine oxidase.
    Langford SD; Trent MB; Boor PJ
    Cardiovasc Toxicol; 2001; 1(1):51-60. PubMed ID: 12213997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Bromoethylamine as a potent selective suicide inhibitor for semicarbazide-sensitive amine oxidase.
    Yu PH; Davis BA; Deng Y
    Biochem Pharmacol; 2001 Mar; 61(6):741-8. PubMed ID: 11266660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.
    Yu PH; Zuo DM
    Diabetologia; 1997 Nov; 40(11):1243-50. PubMed ID: 9389414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzylamine and methylamine, substrates of semicarbazide-sensitive amine oxidase, attenuate inflammatory response induced by lipopolysaccharide.
    Lin Z; Li H; Luo H; Zhang Y; Luo W
    Int Immunopharmacol; 2011 Aug; 11(8):1079-89. PubMed ID: 21414430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes.
    Yu PH; Zuo DM
    Diabetes; 1993 Apr; 42(4):594-603. PubMed ID: 8454111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
    Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K
    Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes.
    Yu PH
    J Neural Transm Suppl; 1998; 52():201-16. PubMed ID: 9564620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.